Prevention of venous thromboembolism.
D000284:Administration, Oral; D000925:Anticoagulants / Q000009:adverse effects; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects; D002056:Burns / Q000150:complications; D003911:Dextrans / Q000009:adverse effects / Q000627:therapeutic use; D004176:Dipyridamole / Q000494:pharmacology; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006886:Hydroxychloroquine / Q000494:pharmacology; D009985:Orthopedics; D011183:Postoperative Complications / Q000517:prevention & control; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000517:prevention & control; D011655:Pulmonary Embolism / Q000209:etiology; D013923:Thromboembolism / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D014570:Urologic Diseases / Q000601:surgery; D014680:Veins
D000925:Anticoagulants; D003911:Dextrans; D006886:Hydroxychloroquine; D004176:Dipyridamole; D006493:Heparin; D001241:Aspirin